These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5451542)

  • 1. Compatibility digest. Aramine bitartrate injection.
    Am J Hosp Pharm; 1970 Aug; 27(8):672-3. PubMed ID: 5451542
    [No Abstract]   [Full Text] [Related]  

  • 2. Physico-chemical incompatibilities of parenteral admixtures Aramine and Solu-Cortef.
    Anderson RW; Latiolais CJ
    Am J Hosp Pharm; 1970 Jul; 27(7):540-7. PubMed ID: 5431052
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorometric determination of metaraminol bitartrate injection.
    Weber JD
    J Assoc Off Anal Chem; 1978 Jul; 61(4):949-50. PubMed ID: 681269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction induced by metaraminol bitartrate (aramine).
    Bernstein A
    J Ir Med Assoc; 1966 Oct; 59(352):127-8. PubMed ID: 6009556
    [No Abstract]   [Full Text] [Related]  

  • 5. SHOCK CAUSED BY CONTINUOUS INFUSION OF METARAMINOL BITARTRATE (ARAMINE).
    SPOEREL WE; SELENY FL; WILLIAMSON RD
    Can Med Assoc J; 1964 Feb; 90(5):349-53. PubMed ID: 14122464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH--an important factor in the compatibility of additives in intravenous therapy.
    Mary Edward Sister
    Am J Hosp Pharm; 1967 Aug; 24(8):440-9. PubMed ID: 6075729
    [No Abstract]   [Full Text] [Related]  

  • 7. Part 2. A guide to admixture compatibility.
    RN; 1973 Nov; 36(11):36-40. PubMed ID: 4490462
    [No Abstract]   [Full Text] [Related]  

  • 8. Part 1. A guide to admixture compatibility.
    RN; 1973 Oct; 36(10):32-7. PubMed ID: 4490450
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical and physical bases determining the instability and incompatibility of formulated injectable drugs.
    Stella VJ
    J Parenter Sci Technol; 1986; 40(4):142-63. PubMed ID: 3534205
    [No Abstract]   [Full Text] [Related]  

  • 11. A factorial design for compatibility studies on preformulation work.
    Leuenberger H; Becher W
    Pharm Acta Helv; 1975; 50(4):88-91. PubMed ID: 1135236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incompatibility of combined injections. I. Salting out].
    Kaczmarczyk F; Modrzejewski F
    Acta Pol Pharm; 1969; 26(6):555-8. PubMed ID: 5380502
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility guide for combining IV medications.
    Ng PK
    Am J Nurs; 1979 Jul; 79(7):1292-5. PubMed ID: 256451
    [No Abstract]   [Full Text] [Related]  

  • 14. A guide to admixture compatibility. Part 3.
    RN; 1973 Dec; 36(12):32-7. PubMed ID: 4490643
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative design of drug compatibility by weighted modification method.
    Zheng QS; Sun RY
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1043-51. PubMed ID: 11270973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemical changes due to the compounding of parenteral injections. (1)].
    Kosugi T
    Iryo; 1967 Aug; 21(8):960-1. PubMed ID: 5582998
    [No Abstract]   [Full Text] [Related]  

  • 19. [TLC of injectable drugs newly adopted at the Nagoya National Hospital].
    Teramoto A
    Iryo; 1969 Dec; 23(12):1570-5. PubMed ID: 5382112
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous therapy. 4. The meaning of incompatibility; specific group incompatibilities.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Apr; 101(4):87-8. PubMed ID: 5907995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.